AEON BIOPHARMA INC (AEON)

US00791X1000 - Common Stock

0.65  +0 (+0.08%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
3.36MN/A
-100.00%		N/AN/A2.407M89.714M
3,627.21%		315.76M
251.96%		560.28M
77.44%
EBITDA
YoY % growth
-53.09MN/A
100.00%		N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
-53.97MN/A
100.00%		N/AN/A
-71.78%		-61.718M
97.41%		-97.704M
-113,509.02%		-33.584M
65.63%		-35.797M
-6.59%		-35.117M
1.90%		27.491M
178.29%		193.26M
602.99%		372.88M
92.94%
Operating Margin
-1,606.25%N/AN/AN/AN/AN/AN/AN/A-1,458.93%30.64%61.20%66.55%
EPS
YoY % growth
N/AN/AN/AN/A-1.190.73
161.54%		-0.70
-195.83%		-0.71
-1.45%		-0.43
40.00%		0.23
154.76%		1.67
613.04%		2.91
73.78%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-0.18
74.14%		-0.19
30.79%		-0.16
-36.00%		-0.17
-92.67%		-0.17
5.56%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-8.139M
71.26%		N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 -0.09
-107.83%		-0.160.0744.85%
Q2 2024
Q2Q % growth		 -0.12 -0.190.0738.08%
Q1 2024
Q2Q % growth		 -0.28 -0.320.0411.45%
Q4 2023
Q2Q % growth		 -0.71 -0.41-0.30-74.02%
Q3 2023
Q2Q % growth		 1.15 -0.541.69312.73%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2021
Q2Q % growth
-100.00%		%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 0% 146.75%
RevenueN/A N/A N/A N/A